Crossmark Global Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
14,107
+9,674
| +218% | +$1.03M | 0.02% | 506 |
|
|
2025
Q1 | $550K | Sell |
4,433
-492
| -10% | -$61.1K | 0.01% | 837 |
|
|
2024
Q4 | $607K | Sell |
4,925
-158
| -3% | -$19.5K | 0.01% | 751 |
|
|
2024
Q3 | $567K | Buy |
5,083
+970
| +24% | +$108K | 0.01% | 815 |
|
|
2024
Q2 | $439K | Sell |
4,113
-1,009
| -20% | -$108K | 0.01% | 888 |
|
|
2024
Q1 | $617K | Sell |
5,122
-42
| -0.8% | -$5.06K | 0.01% | 770 |
|
|
2023
Q4 | $636K | Sell |
5,164
-787
| -13% | -$96.9K | 0.01% | 748 |
|
|
2023
Q3 | $775K | Sell |
5,951
-4,562
| -43% | -$594K | 0.02% | 651 |
|
|
2023
Q2 | $1.38M | Sell |
10,513
-74
| -0.7% | -$9.69K | 0.03% | 510 |
|
|
2023
Q1 | $1.55M | Buy |
10,587
+3,563
| +51% | +$521K | 0.04% | 470 |
|
|
2022
Q4 | $1.12M | Buy |
7,024
+1,115
| +19% | +$178K | 0.03% | 535 |
|
|
2022
Q3 | $788K | Buy |
5,909
+50
| +0.9% | +$6.67K | 0.02% | 619 |
|
|
2022
Q2 | $914K | Sell |
5,859
-60
| -1% | -$9.36K | 0.02% | 599 |
|
|
2022
Q1 | $922K | Buy |
5,919
+240
| +4% | +$37.4K | 0.02% | 652 |
|
|
2021
Q4 | $724K | Sell |
5,679
-710
| -11% | -$90.5K | 0.02% | 753 |
|
|
2021
Q3 | $832K | Sell |
6,389
-150
| -2% | -$19.5K | 0.02% | 670 |
|
|
2021
Q2 | $1.16M | Buy |
6,539
+295
| +5% | +$52.4K | 0.03% | 562 |
|
|
2021
Q1 | $1.03M | Buy |
6,244
+90
| +1% | +$14.8K | 0.03% | 586 |
|
|
2020
Q4 | $1.02M | Buy |
6,154
+1,150
| +23% | +$190K | 0.03% | 573 |
|
|
2020
Q3 | $714K | Buy |
+5,004
| New | +$714K | 0.02% | 638 |
|
|
2018
Q4 | – | Sell |
-2,610
| Closed | -$439K | – | 1471 |
|
|
2018
Q3 | $439K | Buy |
2,610
+120
| +5% | +$20.2K | 0.01% | 1048 |
|
|
2018
Q2 | $429K | Buy |
+2,490
| New | +$429K | 0.01% | 1048 |
|